Cargando…
Marine n‐3 fatty acids and cognitive change among older adults in the VITAL randomized trial
INTRODUCTION: : Few large, randomized trials have evaluated marine n‐3 supplements and cognition in healthy older adults. METHODS: : Healthy community‐dwelling participants aged 60+ years (mean [standard deviation] = 70.9 [5.8] years) in VITAL (randomized trial of n‐3 fats [1 g/day, including 840 mg...
Autores principales: | Kang, Jae H., Vyas, Chirag M., Okereke, Olivia I., Ogata, Soshiro, Albert, Michelle, Lee, I‐Min, D'Agostino, Denise, Buring, Julie E., Cook, Nancy R., Grodstein, Francine, Manson, JoAnn E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984093/ https://www.ncbi.nlm.nih.gov/pubmed/35415212 http://dx.doi.org/10.1002/trc2.12288 |
Ejemplares similares
-
Effect of vitamin D on cognitive decline: results from two ancillary studies of the VITAL randomized trial
por: Kang, Jae H., et al.
Publicado: (2021) -
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease: A Novel Analysis of the VITAL Trial Using Win Ratio and Hierarchical Composite Outcomes
por: Ogata, Soshiro, et al.
Publicado: (2023) -
Lifestyle and behavioral factors and mitochondrial DNA copy number in a diverse cohort of mid-life and older adults
por: Vyas, Chirag M., et al.
Publicado: (2020) -
Effects of Vitamin D(3) and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial
por: Dong, Yanbin, et al.
Publicado: (2022) -
Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial
por: Hahn, Jill, et al.
Publicado: (2022)